Advanced Medical EquipmentS.A.
Manufacture of medical and dental instruments and supplies
Overview
Advanced Medical Equipment is focused on developing a device called Diabetomat, which allows users to measure blood sugar levels without the need for blood samples or needles. This innovative product aims to provide a more comfortable and stress-free experience for diabetics worldwide.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 2.20
- High
- PLN 2.24
- Low
- PLN 2.20
- Volume
- 15.76K
- Avg. vol.
- 2.61K
- Market cap
- PLN 58.78M
- P/E ratio
- 222.00
- EPS
- PLN 0.01
- Shares outstanding
- 26.48M
- 52-week
- PLN 2.10 – 2.28
- Dividend yield
- —
- Dividend
- —
- Ex dividend date
- —
- ISIN
- PLDNMPT00016
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 270.12 | USD -540.25 | USD 810.37 |
| Q1 2026 | USD 0.00 | USD 0.00 | USD 270.12 |
| Q4 2025 | USD 0.00 | USD 1.26k | USD 1.51k |
| Q3 2025 | USD 0.00 | USD -251.13 | USD 0.00 |
Results for Q3 2026:Nov 16, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-06-01. Active
31 1090 1665 0000 0001 5350 5260
57 1050 1025 1000 0090 8242 8872- 79 1050 1025 1000 0090 8242 8864
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the following are authorised to submit declarations of will and sign on behalf of the company: the President of the Management Board and the Vice-President jointly, or one member of the management board jointly with the President, the Vice-President or a commercial proxy.
Supervisory board
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Milton EssexS.A. | $40,863.48 | miltonessex.eu | ||
| Medintechsp. z o.o. | $16,560.95 | medintech.pl | ||
| Telemedical InnovationsS.A. | $872.98 | telemedicalinnovations.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-19 | Share capital change (110,325.50 PLN → 2,647,812.00 PLN) | |
| 2024-04-12 | Share capital change (109,300.00 PLN → 110,325.50 PLN) | |
| 2024-04-10 | Share capital change (105,000.00 PLN → 109,300.00 PLN) | |
| 2024-01-15 | Entered in the register |
FAQ
Last updated: 2026-08-28